The nation’s top brass in the vaccine research and development field descended on Providence this October for The Institute for Immunology and Informatics 4th Annual Vaccine Renaissance Conference.
The conference served as an interactive program for the exchange of ideas among experts in vaccine research, vaccine delivery, clinical trials and basic immunology.
This year’s conference provided a great opportunity to learn about vaccines from the top researchers in the world. Among the guest speakers were Dr. Niranjan Sardesai of Inovio Pharmaceuticals. Dr. Sardesai presented a clinical trial update on the therapeutic HPV vaccine. Dr. Vincent Tuohy of the Lerner College of Medicine at the Cleveland Clinic highlighted his findings on a prophylactic breast cancer vaccination. Dr. Katharine Kripke of the National Institutes of Health provided an update on the current status of HIV vaccine research.
Joining Dr. Kripke from the NIH was renowned immunologist Dr. Polly Matzinger. Dr. Matzinger’s presentation focused on balancing tolerance and intolerance in vaccine design. A reception and award ceremony named in Dr. Matzinger’s honor followed her presentation. Dr. Richard Glass of Bryant University and University of Rhode Island biotech graduate student Roxanne LaCroix were presented the Smart Vaccines for Entrepreneurs award.
Vaccine Renaissance Conference Presentations
Michael Brehm – Humanized Mouse Models for Vaccine Development
Steve Gregory, Phyllis Losikoff, Loren Fast – Immunome-Derived, Multi Epitope, Dendritic Cell Pulsed HCV Vaccine
Daniel Hoft – Romana’s Sign of the Times: Molecular
Bolyn Hubby – Nanoparticle Vaccine Carriers and Adjuvants
William Martin, Matt Ardito, Gary Kurczy – Vaccine Design for Advanced Users: Computer Training: T Cell Epitope Prediction
Katharine Kripke – Good News and Promise for the Future: The Status of HIV Vaccine Research
Tom Mather, Wendy Coy – Salivome-Derived Epitope-Driven Approach to Development of a Tick Vaccine
Ted Ross – VLP’s for Better Vaccine Delivery
Niranjan Sardesai – Therapeutic HPV Vaccine – Clinical Trial Update
Devon Shedlock – Effective T Cell Responses to DNA Vaccines